Randomized, Double-Blind, Multicenter Trial of Hydrogen Water for Parkinson's Disease

被引：26

作者：

Yoritaka, Asako ^{[1
,2
]}

Ohtsuka, Chigumi ^{[3
]}

Maeda, Tetsuya ^{[3
,4
]}

Hirayama, Masaaki ^{[5
]}

Abe, Takashi ^{[6
]}

Watanabe, Hirohisa ^{[7
]}

Saiki, Hidemoto ^{[8
]}

Oyama, Genko ^{[2
]}

Fukae, Jiro ^{[9
]}

Shimo, Yasushi ^{[2
]}

Hatano, Taku ^{[2
]}

Kawajiri, Sumihiro ^{[10
]}

Okuma, Yasuyuki ^{[10
]}

Machida, Yutaka ^{[11
]}

Miwa, Hideto ^{[11
]}

Suzuki, Chikako ^{[12
]}

Kazama, Asuka ^{[13
]}

Tomiyama, Masahiko ^{[14
]}

Kihara, Takeshi ^{[15
]}

Hirasawa, Motoyuki ^{[16
]}

Shimura, Hideki ^{[17
]}

Oda, Eisei

Ito, Mikako ^{[18
]}

Ohno, Kinji ^{[19
]}

Hattori, Nobutaka ^{[2
]}

机构：

[1] Juntendo Univ, Koshigaya Hosp, Dept Neurol, Fukuroyama 560, Koshigaya, Saitama 3430032, Japan

[2] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan

[3] Iwate Med Univ, Dept Internal Med, Sch Med, Div Neurol & Gerontol, Morioka, Iwate, Japan

[4] Res Inst Brain & Blood Vessels, Dept Neurol, Akita, Japan

[5] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi, Japan

[6] Abe Neurol Clin, Dept Neurol, Morioka, Iwate, Japan

[7] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi, Japan

[8] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Neurol, Osaka, Japan

[9] Fukuoka Univ, Dept Neurol, Fukuoka, Japan

[10] Juntendo Univ, Dept Neurol, Shizuoka Hosp, Shizuoka, Japan

[11] Juntendo Univ, Dept Neurol, Nerima Hosp, Tokyo, Japan

[12] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Dept Diagnost Radiol, Stockholm, Sweden

[13] Nozomi Hosp, Saitama, Japan

[14] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan

[15] Rakuwakai Otowa Rehabil Hosp, Dept Neurol, Kyoto, Japan

[16] Tokyo Rinkai Hosp, Dept Neurol, Tokyo, Japan

[17] Juntendo Univ, Urayasu Hosp, Dept Neurol, Chiba, Japan

[18] AC Med Inc, Tokyo, Japan

[19] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi, Japan

来源：

MOVEMENT DISORDERS | 2018年 / 33卷 / 09期

基金：

日本学术振兴会;

关键词：

D O I：

10.1002/mds.27472

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1505 / 1507

页数：3

共 6 条

[1] A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit [J].

Beal, M. Flint ;

Oakes, David ;

Shoulson, Ira ;

Henchcliffe, Claire ;

Galpern, Wendy R. ;

Haas, Richard ;

Juncos, Jorge L. ;

Nutt, John G. ;

Voss, Tiffini Smith ;

Ravina, Bernard ;

Shults, Clifford M. ;

Helles, Karen ;

Snively, Victoria ;

Lew, Mark F. ;

Griebner, Brian ;

Watts, Arthur ;

Gao, Shan ;

Pourcher, Emmanuelle ;

Bond, Louisette ;

Kompoliti, Katie ;

Agarwal, Pinky ;

Sia, Cherissa ;

Jog, Mandar ;

Cole, Linda ;

Sultana, Munira ;

Kurlan, Roger ;

Richard, Irene ;

Deeley, Cheryl ;

Waters, Cheryl H. ;

Figueroa, Angel ;

Arkun, Ani ;

Brodsky, Matthew ;

Ondo, William G. ;

Hunter, Christine B. ;

Jimenez-Shahed, Joohi ;

Palao, Alicia ;

Miyasaki, Janis M. ;

Julie, S. O. ;

Tetrud, James ;

Reys, Liza ;

Smith, Katharine ;

Singer, Carlos ;

Blenke, Anita ;

Russell, David S. ;

Cotto, Candace ;

Friedman, Joseph H. ;

Lannon, Margaret ;

Zhang, Lin ;

Drasby, Edward ;

Kumar, Rajeev .

JAMA NEUROLOGY, 2014, 71 (05) :543-552

[2] Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease [J].

Fu, Yuan ;

Ito, Mikako ;

Fujita, Yasunori ;

Ito, Masafumi ;

Ichihara, Masatoshi ;

Masuda, Akio ;

Suzuki, Yumi ;

Maesawa, Satoshi ;

Kajita, Yasukazu ;

Hirayama, Masaaki ;

Ohsawa, Ikuroh ;

Ohta, Shigeo ;

Ohno, Kinji .

NEUROSCIENCE LETTERS, 2009, 453 (02) :81-85

[3] Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease [J].

Fujita, Kyota ;

Seike, Toshihiro ;

Yutsudo, Noriko ;

Ohno, Mizuki ;

Yamada, Hidetaka ;

Yamaguchi, Hiroo ;

Sakumi, Kunihiko ;

Yamakawa, Yukiko ;

Kido, Mizuho A. ;

Takaki, Atsushi ;

Katafuchi, Toshihiko ;

Tanaka, Yoshinori ;

Nakabeppu, Yusaku ;

Noda, Mami .

PLOS ONE, 2009, 4 (09)

[4]

SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305

[5] A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics [J].

Yoritaka, Asako ;

Abe, Takashi ;

Ohtsuka, Chigumi ;

Maeda, Tetsuya ;

Hirayama, Masaaki ;

Watanabe, Hirohisa ;

Saiki, Hidemoto ;

Oyama, Genko ;

Fukae, Jiro ;

Shimo, Yasushi ;

Hatano, Taku ;

Kawajiri, Sumihiro ;

Okuma, Yasuyuki ;

Machida, Yutaka ;

Miwa, Hideto ;

Suzuki, Chikako ;

Kazama, Asuka ;

Tomiyama, Masahiko ;

Kihara, Takeshi ;

Hirasawa, Motoyuki ;

Shimura, Hideki ;

Hattori, Nobutaka .

BMC NEUROLOGY, 2016, 16

[6] Pilot study of H2 therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial [J].

Yoritaka, Asako ;

Takanashi, Masashi ;

Hirayama, Masaaki ;

Nakahara, Toshiki ;

Ohta, Shigeo ;

Hattori, Nobutaka .

MOVEMENT DISORDERS, 2013, 28 (06) :836-839

← 1 →